Why is Tatva Chintan falling/rising?

As of 04-Nov, Tatva Chintan Pharma Chem Ltd's stock price is rising, currently at 1,531.00, reflecting an increase of 119.25 or 8.45%. The stock has recently hit a new 52-week high of Rs. 1582.85, demonstrating strong performance today with an intraday high increase of 12.12%. It has outperformed its sector by 10.17% and has shown significant trading activity, with delivery volume rising by 232.9% against the 5-day average. Over the past year, the stock has generated a return of 78.62%, which is substantially higher than the market's return of 4.72%. However, it is important to note that while the company has reported a growth in net profit of 49.17% and low debt levels, it faces challenges with poor long-term growth and high valuation metrics.
Broader market context indicates that Tatva Chintan's short-term return of 13.35% over the past week stands in stark contrast to the Sensex, which has declined by 1.38%. This divergence highlights the stock's strong performance relative to the broader market, suggesting that investor sentiment towards Tatva Chintan remains positive despite the overall market conditions. The company's recent positive financial results and market-beating performance contribute to this favorable outlook, although concerns about its long-term growth and high valuation persist.